Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Burrell, James R ^a,b,c   Yiannikas, Con ^c   Rowe, Dominic ^d   Kiernan, Matthew C ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ANZAC Research Institute   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY DETECTION; ANTIBODY TITER; ARM WEAKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; LABORATORY TEST; LOWER MOTOR NEURON SYNDROME; MALE; MOTOR NEURON DISEASE; NERVE CONDUCTION DISORDER; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; TREATMENT RESPONSE; ADOLESCENT; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RECEIVER OPERATING CHARACTERISTIC; SYNDROME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEMOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PHENOTYPE; ROC CURVE; SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80055114985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027041     Document Type: Article

References (29)

1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, et al. (2011) Amyotrophic lateral sclerosis. The Lancet 377: 942-955.
2. Adams D, Kuntzer T, Burger D, Chofflon M, Magistris MR, et al. (1991) Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. Journal of Neuroimmunology 32: 223-230.
3. Lin CS-Y, Krishnan AV, Park SB, Kiernan MC, (2011) Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Arch. Neurol 68: 862-869.
4. van Schaik IN, Bouche P, Illa I, Léger J-M, Van den Bergh P, et al. (2006) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 13: 802-8.
5. Levy JB, Pusey CD, (2000) Nephrotoxicity of intravenous immunoglobulin. QJM 93: 751-755.
6. Hamrock DJ, (2006) Adverse events associated with intravenous immunoglobulin therapy. Int. Immunopharmacol 6: 535-542.
7. Delmont E, Azulay JP, Giorgi R, Attarian S, Verschueren A, et al. (2006) Multifocal motor neuropathy with and without conduction block: A single entity? Neurology 67: 592-596.
8. Olney RK, Lewis RA, Putnam TD, Campellone JV, (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27: 117-21.
9. Vucic S, Cheah BC, Yiannikas C, Vincent A, Kiernan MC, (2010) Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain 133: 2727-2733.
10. Burrell JR, Vucic S, Kiernan MC, (2011) Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12: 283-289.
11. Jakhere S, Wagh V, (2011) Hirayama's disease: the importance of flexion magnetic resonance imaging. J Postgrad Med 57: 48-50.
12. Burke D, Skuse NF, Lethlean AK, (1974) Sensory conduction of the sural nerve in polyneuropathy. J Neurol Neurosurg Psychiatry 37: 647-652.
13. Daube JR, (1991) AAEM minimonograph #11: Needle examination in clinical electromyography. Muscle Nerve 14: 685-700.
14. Brain, (2000) Aids to the Examination of the Peripheral Nervous System. 4th ed. Saunders Ltd.
15. Bouche P, Moulonguet A, Younes-Chennoufi AB, Adams D, Baumann N, et al. (1995) Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 59: 38-44.
16. Kiernan MC, Guglielmi J-M, Kaji R, Murray NMF, Bostock H, (2002) Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125: 664-675.
17. Slee M, Selvan A, Donaghy M, (2007) Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 69: 1680-7.
18. Taylor BV, Wright RA, Harper CM, Dyck PJ, (2000) Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 23: 900-8.
19. Vucic S, Black K, Tick Chong PS, Cros D, (2007) Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration. Clinical Neurophysiology 118: 124-130.
20. Strigl-Pill N, Konig A, Schroder M, Beranek H, Schoser BGH, et al. (2006) Prediction of response to IVIg treatment in patients with lower motor neurone disorders. European Journal of Neurology 13: 135-140.
21. Van den Berg-Vos RM, Franssen H, Wokke JH, Van Es HW, van den Berg LH, (2000) Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 48: 919-26.
22. Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, et al. (2009) Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler 10: 310-323.
23. Cats EA, Jacobs BC, Yuki N, Tio-Gillen AP, Piepers S, et al. (2010) Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology 75: 1961-1967.
24. Ghosh A, Busby M, Kennett R, Mills K, Donaghy M, (2005) A practical definition of conduction block in IvIg responsive multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 76: 1264-1268.
25. Deroide N, Uzenot D, Verschueren A, Azulay J-P, Pouget J, et al. (2007) Triple-stimulation technique in multifocal neuropathy with conduction block. Muscle Nerve 35: 632-6.
26. Vucic S, Howells J, Trevillion L, Kiernan MC, (2006) Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 33: 477-86.
27. Vucic S, Nicholson GA, Kiernan MC, (2008) Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131: 1540-50.
28. Van Den Berg-Vos RM, Van Den Berg LH, Visser J, de Visser M, Franssen H, et al. (2003) The spectrum of lower motor neuron syndromes. J. Neurol 250: 1279-1292.
29. Van Den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, et al. (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 15: 1-9.